Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 19/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | HTR2C | P28335 | 1/20 | 0.48 |
| ▸ | HRH1 | P35367 | 1/20 | 0.48 |
| ▸ | HTR2B | P41595 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31401616 | 0.89 | TACR1 (0.53) | TACR1CYP2D6KCNH2HTR1AHTR2A | |
| SCHEMBL31401611 | 0.80 | TACR1 (0.54) | TACR1CYP2D6KCNH2HTR1AHTR2A | |
| SCHEMBL31401554 | 0.78 | TACR1 (0.60) | TACR1CYP2D6KCNH2HTR1AHTR2A | |
| SCHEMBL6554945 | 0.74 | TACR1 (0.70) | TACR1CYP2D6KCNH2HTR1AHTR2A | |
| SCHEMBL31401519 | 0.74 | TACR1 (0.55) | TACR1CYP2D6KCNH2 | |
| SCHEMBL6554942 | 0.74 | TACR1 (0.70) | TACR1CYP2D6KCNH2HTR1AHTR2A | |
| SCHEMBL6554952 | 0.74 | TACR1 (0.70) | TACR1CYP2D6KCNH2HTR1AHTR2A | |
| SCHEMBL9292866 | 0.74 | TACR1 (0.57) | TACR1CYP2D6KCNH2HTR1AHTR2A | |
| SCHEMBL9292870 | 0.74 | TACR1 (0.57) | TACR1CYP2D6KCNH2HTR1AHTR2A | |
| SCHEMBL9292872 | 0.74 | TACR1 (0.57) | TACR1CYP2D6KCNH2HTR1AHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739655-A2 | SUBSTITUTED 2-PHENYLPIPERIDINE COMPOUNDS FOR USE IN THE DIAGNOSIS, TREATMENT AND/OR PREVENTION OF CANCER | Nestor, Marika (SE) | 2026-05-13 | — | — | EP | claimed |
| WO-2025008409-A2 | SUBSTITUTED 2-PHENYLPIPERIDINE COMPOUNDS FOR USE IN THE DIAGNOSIS, TREATMENT AND/OR PREVENTION OF CANCER | JHA PREETI (US) | 2025-01-09 | — | — | WO | claimed |
| EP-4739655-A2 | SUBSTITUTED 2-PHENYLPIPERIDINE COMPOUNDS FOR USE IN THE DIAGNOSIS, TREATMENT AND/OR PREVENTION OF CANCER | Nestor, Marika (SE) | 2026-05-13 | — | — | EP | disclosed |
| WO-2025008409-A2 | SUBSTITUTED 2-PHENYLPIPERIDINE COMPOUNDS FOR USE IN THE DIAGNOSIS, TREATMENT AND/OR PREVENTION OF CANCER | JHA PREETI (US) | 2025-01-09 | — | — | WO | disclosed |